PMC Articles for MedGen (Select 355856) - PMC

Links from MedGen

Items: 1 to 20 of 500

<< First< Prev

Page of 25

Select item 75943781.

Multicenter phase 2 study of daratumumab monotherapy in patients with previously treated Waldenström macroglobulinemia

Jorge J. Castillo, Edward N. Libby, Stephen M. Ansell, M. Lia Palomba, Kirsten Meid, Catherine A. Flynn, Carly Leventoff, Christopher B. Hergott, Tomasz Sewastianik, Elizabeth A. Morgan, Ruben Carrasco, Jonathan R. Fromm, Guang Yang, Zachary Hunter, Steven P. Treon

Blood Adv. 2020 Oct 27; 4(20): 5089–5092. Published online 2020 Oct 21. doi: 10.1182/bloodadvances.2020003087

PMCID:: PMC7594378

Abstract Article PDF–1011K

Select item 55188842.

Waldenstrom macroglobulinemia cells devoid of BTK^C481S or CXCR4^WHIM-like mutations acquire resistance to ibrutinib through upregulation of Bcl-2 and AKT resulting in vulnerability towards venetoclax or MK2206 treatment

A Paulus, S Akhtar, H Yousaf, A Manna, S M Paulus, Y Bashir, T R Caulfield, M Kuranz-Blake, K Chitta, X Wang, Y Asmann, R Hudec, W Springer, S Ailawadhi, A Chanan-Khan

Blood Cancer J. 2017 May; 7(5): e565. Published online 2017 May 26. doi: 10.1038/bcj.2017.40

PMCID:: PMC5518884

Abstract Article PDF–2.7M

Select item 56246023.

Unintended target effect of anti-BCL-2 DNAi

Abdul Shukkur Ebrahim, Mustapha Kandouz, Nada Emara, Amara B Sugalski, Leonard Lipovich, Ayad M Al-Katib

Cancer Manag Res. 2017; 9: 427–432. Published online 2017 Sep 22. doi: 10.2147/CMAR.S139105

PMCID:: PMC5624602

Abstract Article PDF–850K

Select item 84501384.

Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study

Maria Gavriatopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Efstathios Kastritis, Ioannis P. Trougakos, Meletios A. Dimopoulos

Blood Adv. 2021 Nov 9; 5(21): 4398–4405. Published online 2021 Nov 1. doi: 10.1182/bloodadvances.2021005444

PMCID:: PMC8450138

Abstract Article PDF–970K

Select item 54845805.

A phase 2 study of ofatumumab in Waldenström’s macroglobulinaemia

Richard R Furman¹, Herbert A Eradat, Christine G DiRienzo, Craig C Hofmeister, Suzanne R Hayman, John P Leonard, Morton Coleman, Ranjana Advani, Asher Chanan-Khan, Julie Switzky, Qiming M Liao, Damini Shah, Roxanne C Jewell, Steen Lisby, Thomas S Lin

Lancet Haematol. Author manuscript; available in PMC 2018 Jan 1.

Published in final edited form as: Lancet Haematol. 2017 Jan; 4(1): e24–e34. Published online 2016 Dec 1. doi: 10.1016/S2352-3026(16)30166-1

PMCID:: PMC5484580

Abstract Article PDF–411K

Select item 35789516.

Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemia

Irene M. Ghobrial, Federico Campigotto, Timothy J. Murphy, Erica N. Boswell, Ranjit Banwait, Feda Azab, Stacey Chuma, Janet Kunsman, Amanda Donovan, Farzana Masood, Diane Warren, Scott Rodig, Kenneth C. Anderson, Paul G. Richardson, Edie Weller, Jeffrey Matous

Blood. 2013 Feb 21; 121(8): 1296–1303. Prepublished online 2013 Jan 3. doi: 10.1182/blood-2012-06-439307

PMCID:: PMC3578951

Abstract Article

Select item 101196237.

A false positive serology test of SARS‑CoV‑2 in a patient with Waldenström's macroglobulinemia: A case report

Ni-Na Lu, Ling-Zhi Liang, Xiao-Yuan Yan, Bi-Ying Song, Ya-Qiong Zhang, Hai-Rong Shu, Ling-Long Xu

Exp Ther Med. 2023 May; 25(5): 200. Published online 2023 Mar 21. doi: 10.3892/etm.2023.11899

PMCID:: PMC10119623

Abstract Article PDF–814K

Select item 95963088.

Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenström's macroglobulinemia in a single-arm, multicenter, open-label, phase 2 study

Xin-xin Cao, Jie Jin, Cheng-cheng Fu, Shu-hua Yi, Wei-li Zhao, Zi-min Sun, Wei Yang, Deng-ju Li, Guo-hui Cui, Jian-da Hu, Ting Liu, Yong-ping Song, Bing Xu, Zun-min Zhu, Wei Xu, Ming-zhi Zhang, Ya-min Tian, Bin Zhang, Ren-bin Zhao, Dao-bin Zhou

eClinicalMedicine. 2022 Oct; 52: 101682. Published online 2022 Oct 4. doi: 10.1016/j.eclinm.2022.101682

PMCID:: PMC9596308

Abstract Article PDF–1.0M

Select item 112294459.

A phase 2, open-label study of ibrutinib plus rituximab in Japanese patients with Waldenstrom’s macroglobulinemia

Koji Izutsu, Hisashi Kato, Naohiro Sekiguchi, Tomoaki Fujisaki, Toshiro Kawakita, Naoshi Obara, Kosei Matsue, Mitsutaka Nishimoto, Tomoyoshi Hatayama, Mitsuo Inagaki, Ei Fujikawa

Int J Hematol. 2024; 120(1): 80–90. Published online 2024 Apr 10. doi: 10.1007/s12185-024-03761-9

PMCID:: PMC11229445

Abstract Article PDF–1.0M

Select item 190532810.

Enhanced B cell survival in familial macroglobulinaemia is associated with increased expression of Bcl-2

H M Ögmundsdóttir, S Sveinsdóttir, Á Sigfússon, I Skaftadóttir, J G Jónasson, B A Agnarsson

Clin Exp Immunol. 1999 Aug; 117(2): 252–260. doi: 10.1046/j.1365-2249.1999.00971.x

PMCID:: PMC1905328

Abstract Article PDF–248K

Select item 658596011.

An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma

David J. Andorsky, Kathryn S. Kolibaba, Sarit Assouline, Andres Forero‐Torres, Vicky Jones, Leonard M. Klein, Dipti Patel‐Donnelly, Mitchell Smith, Wei Ye, Wen Shi, Christopher A. Yasenchak, Jeff P. Sharman

Br J Haematol. 2019 Jan; 184(2): 215–222. Published online 2018 Sep 5. doi: 10.1111/bjh.15552

PMCID:: PMC6585960

Abstract Article PDF–223K

Select item 114100812.

Cell surface expression of beta 2-microglobulin (beta 2m) correlates with stages of differentiation in B cell tumours.

R A Jones, C S Scott, D R Norfolk, A N Stark, J A Child

J Clin Pathol. 1987 May; 40(5): 486–489. doi: 10.1136/jcp.40.5.486

PMCID:: PMC1141008

Summary Page Browse PDF–508K

Select item 801074013.

BTK inhibitors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Systematic Review

Michael Stack, Keith Sacco, Riccardo Castagnoli, Alicia A. Livinski, Luigi D. Notarangelo, Michail S. Lionakis

Version 1. Res Sq. Preprint. 2021 Mar 22. doi: 10.21203/rs.3.rs-319342/v1

Published in:: Clin Immunol. 2021 Sep; 230: 108816.

PMCID:: PMC8010740

Abstract Article PDF–579K

Select item 1055861214.

Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up

Alexander Röth, Catherine M. Broome, Wilma Barcellini, Tor Henrik Anderson Tvedt, Yoshitaka Miyakawa, Shirley D’Sa, David Cella, Sylvie Bozzi, Deepthi Jayawardene, Ronnie Yoo, Frank Shafer, Marek Wardęcki, Ilene C. Weitz

Blood Adv. 2023 Oct 10; 7(19): 5890–5897. Published online 2023 Jul 19. doi: 10.1182/bloodadvances.2022009318

Correction in:: Blood Adv. 2024 Jun 11; 8(11): 2650.

PMCID:: PMC10558612

Abstract Article PDF–495K

Select item 934983115.

SARS‐CoV‐2 humoral responses following booster BNT162b2 vaccination in patients with B‐cell malignancies

Evangelos Terpos, Despina Fotiou, Vangelis Karalis, Ioannis Ntanasis‐Stathopoulos, Aimilia D. Sklirou, Maria Gavriatopoulou, Panagiotis Malandrakis, Vassiliki A. Iconomidou, Efstathios Kastritis, Ioannis P. Trougakos, Meletios A. Dimopoulos

Am J Hematol. 2022 Oct; 97(10): 1300–1308. Published online 2022 Aug 2. doi: 10.1002/ajh.26669

PMCID:: PMC9349831

Abstract Article PDF–2.5M

Select item 934936816.

Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti‐spike neutralizing IgG to SARS‐CoV‐2 variants, but preserved antigen‐specific T cell responses

Brendan Beaton, Sarah C. Sasson, Katherine Rankin, Juliette Raedemaeker, Alexander Wong, Priyanka Hastak, Chansavath Phetsouphanh, Andrew Warden, Vera Klemm, C. Mee Ling Munier, Alexandra Carey Hoppe, Fiona Tea, Aleha Pillay, Alberto Ospina Stella, Anupriya Aggarwal, Orly Lavee, Ian D. Caterson, Stuart Turville, Anthony D. Kelleher, Fabienne Brilot, Judith Trotman

Am J Hematol. 2022 Jun 9 : 10.1002/ajh.26619. doi: 10.1002/ajh.26619 [Epub ahead of print]

PMCID:: PMC9349368

Abstract Article PDF–1.5M

Select item 487424617.

Low expression of pro-apoptotic Bcl-2 family proteins sets the apoptotic threshold in Waldenström Macroglobulinemia

Brian T. Gaudette, Bhakti Dwivedi, Kasyapa S. Chitta, Stéphanie Poulain, Doris Powell, Paula Vertino, Xavier Leleu, Sagar Lonial, Asher A. Chanan-Khan, Jeanne Kowalski, Lawrence H. Boise

Oncogene. Author manuscript; available in PMC 2016 May 21.

Published in final edited form as: Oncogene. 2016 Jan 28; 35(4): 479–490. Published online 2015 Apr 20. doi: 10.1038/onc.2015.103

PMCID:: PMC4874246

Abstract Article PDF–1.1M

Select item 4818218.

Monoclonal IgM rheumatoid factors bind IgG at a discontinuous epitope comprised of amino acid loops from heavy-chain constant-region domains 2 and 3.

S E Artandi, K L Calame, S L Morrison, V R Bonagura

Proc Natl Acad Sci U S A. 1992 Jan 1; 89(1): 94–98. doi: 10.1073/pnas.89.1.94

PMCID:: PMC48182

Summary Page Browse PDF–1.2M

Select item 1071107919.

Broadening the horizon: potential applications of CAR-T cells beyond current indications

Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, Walter Fiedler, Winfried Alsdorf, Andreas Block

Front Immunol. 2023; 14: 1285406. Published online 2023 Nov 27. doi: 10.3389/fimmu.2023.1285406

PMCID:: PMC10711079

Abstract Article PDF–2.1M

Select item 1066698720.

Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study

Meletios A. Dimopoulos, Stephen Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G. Owen, Paula Marlton, Björn E. Wahlin, Ramon Garcia-Sanz, Helen McCarthy, Stephen Mulligan, Alessandra Tedeschi, Jorge J. Castillo, Jaroslaw Czyz, Carlos Fernández de Larrea, David Belada, Edward Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trněný, Monique C. Minnema, Christian Buske, Veronique Leblond, Steven P. Treon, Judith Trotman, Wai Y. Chan, Jingjing Schneider, Heather Allewelt, Sheel Patel, Aileen Cohen, Constantine S. Tam

J Clin Oncol. 2023 Nov 20; 41(33): 5099–5106. Published online 2023 Jul 21. doi: 10.1200/JCO.22.02830

PMCID:: PMC10666987

Abstract Article PDF–908K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 1 to 20 of 500

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity